Badi M Boulos
Associate Professor Emeritus
Environmental & Occupational Health Sciences
106 Sphw, M/c 922
2121 W. Taylor St
Chicago, IL 60612
312-996-0803
Academic Background
- M.D., U Alexandria, 1953
Medical Technology - DO, Univ of Missouri Cntl Ofc, 1964
Unknown Major - DO, Univ of Missouri Sys Ofc, 1964
Pharmacology
Toxicology
- DO, Univ of Missouri Sys Ofc, 1964
Pharmacology - MSO, Univ of Iowa, 1961
Radiation Biology
Unknown Major
- MSO, Univ of Iowa, 1961
Radiation Biology
Research Interests
- Placental transfer of pollutants and compounds and hazards to the unborn fetus, basic toxicology, carcinogenesis, industrial, environmental and clinical toxicology with examples as health hazards in the arts and crafts
Teaching Interests
- Toxicology, environmental and industrial hazards, occupational and environmental medicine
Publications
- Boulos,B.M., Zalzaleh,G.,Jajeh,A.,et al.Rituximab in the Treatment of Adults with Chronic Idiopathic Thrombocytopenic Purpura (ITP) and Autoimmune Hemolytic Anemia(AIHA).FASEB 18(5)648.3-A994,2004
- Boulos,B.M.,Jajeh,A. et al.Potentiating Effect of Pentostatin and Alkylating Agents in Refractory or Relapsed Chronic Lymphocytic Leuckemia (CLL).FASEB l9(4)324.12-A557,2005
- Boulos, B.M.,Jajeh, A. et al,Thalidomide in Multiple Myeloma.FASEBl9(4)324.11-A550 2005
- Badi M. Boulos, Jajeh,A. et al.Imitinab(Gleevec)in The Treatmentbof Chronic Myeloid Leukemia (CML). FASEB 20(5)705.12,2006
- Boulos, B., Jajeh, A., Tamkus, D. Menini, P. et al. Gemcitabine in the Treatment of Relapsed Lymphomas. FASEB 17(5), 732.10-A483, 2008
- Rituximab in The Treatment of Adults with Chronic Idiopathic Thrombocytopenic Purpura (ITP)and Autoimmune Hemolytic Anemia (AIHA).FASEB l8(5)A95,2004
- InterLukin 4 and Hematophagocytosis FASEBl7(5):661-4,2003
Administrative Units
- Academic Affairs
- Advancement
- Community and Public Health Practice
- Finance and Resource Planning
- Information Technology
- Research Services
- Student Affairs
- Urban Health and Diversity Programs
SPH Events
To see more SPH Events.
